Blog
RSS FeedPosted by Michael Wonder on 18 Jul 2016
Merck receives European Medicines Agency acceptance for review of marketing authorization application for cladribine tablets
18 July 2016 - Merck today announced that the EMA has accepted for review the marketing authorisation application of the ...
Posted by Michael Wonder on 05 Jul 2016
Biogen and AbbVie’s once-monthly Zinbryta (daclizumab) approved in European Union for treatment of multiple sclerosis
5 July 2016 - Zinbryta significantly reduced multiple measures of disease activity in patients with relapsing forms of multiple sclerosis. ...
Posted by Michael Wonder on 11 Sep 2015
Merck intends to submit cladribine tablets to treat multiple sclerosis for registration in Europe
11 September 2015 -Merck, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials ...